ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

XLO Xilio Therapeutics Inc

1.07
0.06 (5.94%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Xilio Therapeutics Inc XLO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.06 5.94% 1.07 13:00:11
始値 安値 高値 終値 前日終値
1.02 1.02 1.11 1.09 1.01
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0205:05GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
2024/3/2820:05GLOBEXilio Therapeutics Announces $11.3 Million Private Placement..
2024/3/2820:00BWGilead and Xilio Announce Exclusive License Agreement for..
2024/2/2906:01GLOBEXilio Therapeutics to Participate in Novel Immuno-Oncology..
2024/2/0106:01GLOBEXilio Therapeutics to Present at Guggenheim 6th Annual..
2024/1/2006:30EDGAR2Form 8-K - Current report
2024/1/0821:30GLOBEXilio Therapeutics Highlights Recent Advances Across..
2024/1/0406:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:05EDGAR2Form 8-K - Current report
2023/12/0721:45EDGAR2Form 8-K - Current report
2023/12/0721:30GLOBEXilio Therapeutics Announces Initiation of Enrollment for..
2023/11/1006:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1006:13EDGAR2Form 8-K - Current report
2023/11/1006:10EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
2023/11/1006:08EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
2023/11/1006:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
2023/11/1006:01GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
2023/11/0405:05EDGAR2Form 8-K - Current report
2023/11/0401:00GLOBEXilio Announces Initial Monotherapy Safety and Anti-Tumor..
2023/10/3122:15GLOBEXilio to Host Virtual Investor Conference Call and Webcast..
2023/9/2806:02GLOBEXilio Therapeutics Announces Upcoming Presentations at the..
2023/9/0805:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0805:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/9/0521:35EDGAR2Form 8-K - Current report
2023/9/0521:30GLOBEXilio Therapeutics Announces Promotion of Katarina..
2023/9/0520:30GLOBEXilio Therapeutics to Present at Morgan Stanley 21st Annual..
2023/8/1909:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1909:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1420:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1420:40EDGAR2Form 8-K - Current report
2023/8/1420:30GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
2023/8/0805:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0805:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/0405:15EDGAR2Form 8-K - Current report
2023/8/0405:05GLOBEXilio Therapeutics Announces Promotion of Chris Frankenfield..
2023/5/2606:01GLOBEXilio Therapeutics Announces Preliminary Clinical Data from..
2023/5/0920:30GLOBEXilio Therapeutics Announces Pipeline and Business Updates..

最近閲覧した銘柄

Delayed Upgrade Clock